Current Trends in Pharmacy and Pharmaceutical Chemistry

Online ISSN: 2582-5062

Current Trends in Pharmacy and Pharmaceutical Chemistry is the official Journal of Ateos Foundation of Science Education and Research, hosted and Managed IP Innovative Publications Pvt. Ltd, New Delhi, India. Current Trends in Pharmacy and Pharmaceutical Chemistry is an open access, peer-reviewed quarterly international journal publishing since 2019 and is published under auspices of the Ateos Foundation of Science Education and Research. It aims to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 426

PDF Downloaded: 160


Get Permission Jerubin Welsingh, Xavier Arulappa, and Shankarananth: Analytical method development and validation of ornidazole by using uv spectroscopy


Introduction

Protozoal infections are a major cause of disease in countries where hygiene conditions are lesser. These unicellular protozoan cells are more or less resembling eukaryotic and hence have metabolic functions closer to human host cells. They include amoebiasis, giardiasis, trichomoniasis, trypanosomiasis, toxoplasmosis and leishmaniasis. The amoebic infection caused by Entamoeba histolytica could be Asymptomatic or may present as mild to moderate colitis or as dysentery or as liver abscess. This Entamoeba histolytica exist in two forms 1. Cyst form (survives outside the host body), 2.Trophozoites (Survives within the host body).

This Ornidazole, chemically (2S)-1-chloro-3-(2-methyl-5- nitro-1H- imidazol-1-yl) propan-2-ol, with molecular formula C7H10N3O3Cl. Ornidazole is a 5-nitroimidazole derivative. It is converted to reduction products that interact with DNA of the microorganism, to cause destruction of helical DNA structure and strand, leading to a protein synthesis inhibition and cell death in susceptible organisms. It is an official drug in Indian pharmacopoeia.

Aim and Objective

The aim of the present work is to develop a simple, precise, accurate and sensitive method using visible spectrophotometry. The method is a derivatization technique which involves reduction of nitro group of ornidazole by reacting with Zn/HCl (Clemmenson reduction) to form amino compound followed by formation of diazonium salt by reacting with Sodium Nitrite in Conc HCl. This Diazonium salt reacts with aromatic compound having ortho para directing -OH group to yield yellow coloured complex which is measured by Double beam UV spectrophotometry of Systronics.

In this method development technique the Nitro group of ornidazole is reduced by Clemmenson reduction to form an amino derivative. This amino group is reacted with NaNO2 /Conc HCl to form diazonium salt. This diazonium salt reacts with Phloroglucinol to form a diazo-coupling compounds, which gives yellow colored Hydroxy azo derivative. The UV absorption of this colored derivative is measured at 430 nm. A standard linear graph is obtained. The ornidazole tablet sold in the market is compared with the Standard linear graph. The results are tabulated, compared and reported.

Method development

The reaction of Diazonium salt with aromatic compounds having Ortho para directing groups like -OH, - NH2 to yield Diazo coupling product is called Diazo coupling reaction. This pH should be carefully monitored at acidic condition to enhance the reaction

Figure 0
https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a934f2c3-4cfb-4b05-b1d8-ab63be75d105image1.png

Ornidazole has a nitro group (-NO2) at its 5 th position of the imidazole nucleus. This nitro group on treatment with zinc dust in HCl (Clemmenson reduction), gets reduced to Primary amino group. This primary amino group on reacting with sodium nitrite in conc HCl (Nitrous acid is formed insitu), forms diazonium salt. This diazonium salt is reacted with phloroglucinol to yield diazo coupling product (yellow colored product). The UV absorption at 430 nm of this colored diazo coupling product forms the basis for this method development.

The nitrous acid formed in excess can be removed by adding ammonium sulphamate in acid condition, so that the nitrous acid gets converted to Nitrogen gas and sulphuric acid.

Figure 0
https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a934f2c3-4cfb-4b05-b1d8-ab63be75d105image2.png

Materials Used

Instruments

UV Spectrophotometer

UV Visible Double beam spectrophotometer 2704-x- system with matched quartz cells.

Reagents

  1. Active Pharmaceutical Ingredient “ORNIDAZOLE” (Supplied from Stedmann Pharmaceuticals, Chennai)

  2. Distilled water

  3. Sodium hydroxide

  4. Ammonium Sulfamate

  5. Phloroglucinol

  6. Concentrated Hydrochloric acid

  7. Sample tablet

  8. Tablet Formulation Available Market: ORNI 500

  9. Manufacturer: Zydus Cadilla.

Sample bablet

  1. Tablet Formulation Available Market: ORNI 500

  2. Manufacturer: Zydus Cadilla

Parameter estimated

  1. Determination of absorption maximum (λ max)

  2. Linearity (beer’s law concentration range)

  3. Estimation of dosage form

  4. Accuracy (recovery study)

Establishment of parameter

  1. Absorption Maximum (λ max)

  2. Beer’s Law concentration (linearity)

Preparation of Standard Drug Solution:1

Chart 1
https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a934f2c3-4cfb-4b05-b1d8-ab63be75d105image3.png

Zn /Hcl Reduction: 200mg zinc powder + 5ml water + 2.5ml of 4NHcl. keep it for reduction for 1 hour and then filter it.

Absorption maximum

It is wavelength of light at which a substance shows maximum absorbance. The standard stock solution is diluted to 25mg/ml and scanned over a visible region of 400-500nm. The absorption values were tabulated to find the absorption maximum. Then the absorption maximum was found at the wavelength of 430nm.

Chart 2
https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a934f2c3-4cfb-4b05-b1d8-ab63be75d105image4.png

Add 1 ml of sodium hydroxide and 1ml of Conc Hcl and wait for 5 minutes and add 1 ml of ammonium sulfamate and 1 ml of phloroglucinol solution and makeup to 10ml with distilled water.

Linearity

Beer’s Law Concentraton Range

Figure 1
https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a934f2c3-4cfb-4b05-b1d8-ab63be75d105image5.png

The stock solution was suitably diluted with distilled water to get various concentration of ornidazole and their absorbance was measured and was found that ornidazole obeys beer’s law.

Table 1

Concentration in μg

Quantity in ml

Absorbance

5

0.5

0.162

10

1.0

0.325 std absorbance

15

1.5

0.484

20

2.0

0.643

25

2.5

0.813

Preparation of test solution

Twenty tablets (Brand: ORNI 500) were weighed and the label claim of tablet content is noted and the average weight of each tablet was calculated.

Average weight of 20 tablets = 0.6576 gm Label claim or tablet content = 500 mg Test sample powder quantity to be taken

Equivalent to 0.025 gm (25mg) =Avg weight Lable claimX weight to be taken

Five tablet were powdered individually and a quantity equivalent to 0.025gm of powder was taken from each tablet in separate flask and it was subjected to Clemmenson reduction using Whatman filter paper and makeup to 25ml and, from this take 5ml and make up to 50 ml, From this 1ml of solution is taken and add 1ml of 0.1% sodium Nitrite and add Conc Hcl 1ml and wait for 5 minutes. Then add 1 ml of 0.5% Ammonium sulfamate and 1ml of 0.5% phloroglucinol and makeup to 10 ml with distilled water in a standard flask.1, 2, 3 The content of Ornidazole present in each tablet of average weight is calculated

Table 2

S.no

Weight equivalent of tablet powder taken

Absorbance (nm)

Content of Ornidazole

1

0.032

0.315

0.497

2

0.033

0.320

0.490

3

0.034

0.331

0.492

4

0.035

0.341

0.492

5

0.036

0.351

0.493

Recovery Study (Accuracy) by Standard addition method.

Preparation of standard drug solution

0.025 gm of pure standard drug is made up to 25 ml using distilled water (1ml=0.001gm)

Preparation of test sample for recovery study

032gm of tablet powder equivalent to 25mg of pure drug was taken

Add 5ml (5mg) of above standard drug solution .This mixture is subjected to clemmenson reduction (Zn /Hcl), filter using filter paper make up 25 ml with distilled water and for, this dilution is done as per flow chart.[4-7]4, 5, 6 This procedure is carried out for five tablet as individual methods and the absorbance is measured

Chart 3
https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a934f2c3-4cfb-4b05-b1d8-ab63be75d105image6.png

Table 3

Tablet . No

Absorbance

Amount present in each tablet

Percentage of content

1.

0.318

0.502

100.4 %

2.

0.324

0.496

99.2 %

3.

0.335

0.498

99.6 %

4.

0.345

0.498

99.6 %

5.

0.355

0.498

99.6 %

Average of test absorbance

Average content Present gm / tablet

Standard deviation for content present in tablet

Avg % Label claim %w/w

%Deviation

0.335

0.498

0.00195959

99.68

0.32

Result and Discussion

  1. The maximum absorbance of ornidazole was found to be 430nm from table no.1 five different standard solution of concentration 5,10,15,20,25, μg were prepared and the absorbance are found out and the linearity graph was plotted.

  2. The quantitative estimation was carried out by taking the concentration of 100 μg/ ml. For five test sample tablets of ORNI 500 and their individual absorbance was noted in the table no.3 . More over the content of the ornidazole present in gram in all five tablet were calculated

  3. The recovery study (Accuracy) is also performed by the standard addition method on adding 5mg standard drug of ornidazole to each tablet sample and their absorbance with content present in each tablet is shown in table no :4

  4. The average of test absorbance an its standard deviation were calculated.

    1. The average content in gms present in each tablet and it standard deviation were calculated. The percentage label claim was found to be 99.68% w/w and percentage deviation from label claim was found to be

    2. 0.32 % w/w.

Conclusion

  1. Ornidazole was determined by a new method of formation of Diazo coupled product which produces a visible colour in acid medium. Distilled water was used as solvent. From the analytical and statistical data obtained, the method can be accurately applied for the determination of ornidazole present in formulation. The maximum absorption was found to be 430nm and the linearity range was found as 5-25 μg.

  2. The recovery study shows a percentage label claim of 99.68% w/w and a percentage deviation from label claim were found to be 0.32%w/w. This recovery study by standard addition method states that this method can be successfully used for estimation of ornidazole.

Acknowledgment

The author wishes to thank the principal Dr. V. Shankarananth and the Honorable Chairman Dr. Jacob Raja MDS, FIDA., for their encouragement and support.

Source of Funding

None.

Conflict of Interest

None.

References

1 

P Jyosta R Malathi P Swetha Analytical method development and validation of ornidazole in tablet dosage formInt J Pharm Pharm Sci201683https://journals.innovareacademics.in/index.php/ijpps/article/view/10406/4849

2 

PS Neha D Dulendra BN Sachin Analytical method development and validation of ornidazole, ofloxacin and racecadotril in Pharmaceutical dosage forms by HPLCThe Pharm Inno20198822834

3 

V Hemangi P Sweetu P Divya KP Prasanna Analytical method development and validation of diloxanide furoate and ornidazole in its combined pharmaceutical dosage formSch Acad J Pharm201549398404

4 

VS Oksana YK Lina VS Zoia AU Vera SS Oleg Application of thin layer chromatography in analysis of secnidazole, ornidazole, tinidazole and nimorazoleJ Pharm Sci Res2018101234116

5 

AS Grewal SK Bhradwaj SK Patro SK Kanungo Visible spectrometric estimation o ornidazole in pure and phqrmaceutical formulationInt J Che Tec Res20124310448

6 

B Dhandapani N Thirumoorthy HR Shaik R Kotaiah M Anjaneyalu Method development and validation for the simultaneous estimationInt J Pharm Sci Res2010117883



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

18-22


Authors Details

M. Jerubin Welsingh, R. Xavier Arulappa, V. Shankarananth


Article History

Received : 09-11-2023

Accepted : 30-11-2023


Article Metrics


View Article As

 


Downlaod Files